T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform
- DOI
- 10.3389/fimmu.2025.1723110
- Published
- 2026-01-12
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2025.1723110,
title = {T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform},
author = {Sophie Tourdot and Anette Christine Karle and Marc Rosenbaum and Chloé Ackaert and Pauline Le Vu and Michael Gutknecht and Maryam Ahmadi and Annelies W. Turksma and Timothy P. Hickling},
year = {2026},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2025.1723110},
url = {https://doi.org/10.3389/fimmu.2025.1723110}
}RIS
TY - JOUR TI - T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform AU - Sophie Tourdot AU - Anette Christine Karle AU - Marc Rosenbaum AU - Chloé Ackaert AU - Pauline Le Vu AU - Michael Gutknecht AU - Maryam Ahmadi AU - Annelies W. Turksma AU - Timothy P. Hickling PY - 2026 JO - Frontiers in Immunology DO - 10.3389/fimmu.2025.1723110 UR - https://doi.org/10.3389/fimmu.2025.1723110 ER -
APA
Tourdot, S., Karle, A. C., Rosenbaum, M., Ackaert, C., Vu, P. L., Gutknecht, M., Ahmadi, M., Turksma, A. W., & Hickling, T. P. (2026). T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1723110
Source records
- crossref · retrieved 2026-09-27T12:08:06.949Z